Equities

Angelalign Technology Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Angelalign Technology Inc

Actions
Health CareMedical Equipment and Services
  • Price (HKD)75.15
  • Today's Change-0.80 / -1.05%
  • Shares traded83.80k
  • 1 Year change+28.24%
  • Beta1.3583
Data delayed at least 15 minutes, as of Feb 16 2026 04:08 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Angelalign Technology Inc is an investment holding company mainly engaged in the provision of clear aligner solutions. The Company’s main business is engaged in providing dental professionals and patients with comprehensive digital orthodontic solutions. The Company’s main products include angelalign Pro, angelalign, angelalign KID and other products. The Company has developed iOrtho Digital Orthodontic Intelligent Service Platform, covering the entire digital orthodontic workflow, connecting dental professionals, patients, products and services from initial patient consultation, auxiliary diagnosis, plan design, and production to process monitoring. The Company conducts its business in the domestic and overseas markets.

  • Revenue in HKD (TTM)2.43bn
  • Net income in HKD184.75m
  • Incorporated2018
  • Employees3.54k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shanghai INT Medical Instruments Co Ltd1.04bn202.40m6.54bn2.01k25.672.5721.156.281.211.216.2212.060.38022.0511.49600,349.607.988.4610.149.8160.9960.3421.0024.360.96626.740.225324.3113.1724.3615.6312.6817.46--
China Isotope & Radiation Corp8.62bn479.84m6.56bn3.36k13.681.145.010.76121.501.5026.9617.970.51863.141.752,561,072.006.226.3112.9912.9948.2655.5411.9911.951.5168.900.27530.1614.1613.689.624.3311.8123.56
BrainAurora Medical Technology Ltd192.86m-237.94m6.61bn174.00--22.03--34.30-0.1879-0.18790.15230.22110.3274--1.241,212,958.00-40.54---112.29--41.26---123.83-----10.130.6324--82.01--44.78------
MicroPort NeuroScientific Corp833.17m230.32m6.86bn522.0029.853.5123.168.230.3990.3991.443.400.35431.293.101,580,970.009.696.0411.237.0173.5874.5827.3616.604.71142.060.014135.6914.4432.9074.6340.172.49--
AK Medical Holdings Ltd1.57bn334.06m6.91bn1.00k20.612.2315.154.420.29840.29841.402.750.4111.062.661,640,641.008.778.0110.899.6959.2763.0121.3420.182.88--0.074722.5723.087.7650.420.51418.660.1873
Zylox-Tonbridge Medical Technolgy Co Ltd1.02bn172.63m7.89bn875.0044.022.1036.827.760.53160.53163.1411.120.25731.40425.711,161,637.004.37-3.214.84-3.4471.4772.7516.98-21.205.16--0.0257--48.27175.65227.34--35.70--
LifeTech Scientific Corp1.50bn81.35m7.92bn1.27k91.391.8667.325.270.01870.01870.34570.92090.26150.69758.111,078,952.000.48166.080.58227.2672.6078.531.8420.722.09--0.13080.002.8814.28-15.5211.4715.11--
Xunfei Healthcare Technology Co Ltd908.82m-87.15m10.53bn928.00--10.56--11.58-0.721-0.7217.528.250.44713.361.11997,604.40-4.80---11.06--54.37---10.73--1.49--0.3613--31.98--8.45------
Angelalign Technology Inc2.43bn184.75m12.83bn3.54k68.883.4541.785.291.091.0914.3421.760.41956.808.48679,033.102.994.484.105.7362.5263.837.1311.672.69--0.1587--28.2323.5160.883.9814.40--
QingSong Health Corp1.41bn91.01m17.51bn205.00192.41--181.5812.420.4410.4416.83-6.20------7,228,269.00--------32.06--6.46------3.27--92.87---90.75------
Data as of Feb 16 2026. Currency figures normalised to Angelalign Technology Inc's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

13.34%Per cent of shares held by top holders
HolderShares% Held
Goldman Sachs International (Invt Mgmt)as of 05 Feb 202610.32m6.04%
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 30 Jun 20252.89m1.69%
Aegon-Industrial Fund Management Co., Ltd.as of 30 Jun 20252.71m1.59%
The Vanguard Group, Inc.as of 04 Feb 20262.00m1.17%
Zhong Geng Fund Management Co. , Ltd.as of 30 Jun 20251.73m1.01%
Orient Securities Asset Management Co. Ltd.as of 30 Jun 2025921.00k0.54%
BlackRock Fund Advisorsas of 06 Feb 2026858.40k0.50%
E Fund Management Co., Ltd.as of 30 Jun 2025478.40k0.28%
Bosera Asset Management Co., Ltd.as of 30 Jun 2025457.40k0.27%
Huisheng Fund Management Co., Ltd.as of 30 Jun 2025420.40k0.25%
More ▼
Data from 30 Jun 2025 - 12 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.